Pancreatic Cancer Research

ResearcherZhengzhou UniversityNo recent work listed

Xiaoyong Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7754-731X; OpenAlex author ID A5100673952. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 3

  1. Telomere-related prognostic biomarkers for survival assessments in pancreatic cancer. Co-author DOI 10.1038/s41598-023-37836-0↗
  2. Development and validation of a competing risk model for second primary pancreatic ductal adenocarcinoma: A population-based study. Last author DOI 10.3389/fsurg.2022.934148↗
  3. Prognostic factor analysis of irreversible electroporation for locally advanced pancreatic cancer - A multi-institutional clinical study in Asia. Co-author DOI 10.1016/j.ejso.2019.12.006↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shengyang Chen · 2 shared papers, 2022–2023 · strength 0.34
  2. Genhao Zhang · 1 shared paper, 2023 · strength 0.18
  3. Lishan Song · 1 shared paper, 2022 · strength 0.15
  4. Po‐Chih Yang · 1 shared paper, 2020 · strength 0.13
  5. Shengping Li · 1 shared paper, 2020 · strength 0.13
  6. Uei Pua · 1 shared paper, 2020 · strength 0.13
  7. Man Deuk Kim · 1 shared paper, 2020 · strength 0.13
  8. Po‐Chin Liang · 1 shared paper, 2020 · strength 0.13
  9. Kai‐Wen Huang · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.